Literature DB >> 18043541

Sustainable production of orphan radionuclides at Wisconsin.

R J Nickles1, M A Avila-Rodriguez, J A Nye, E N Houser, R G Selwyn, M J Schueller, B T Christian, M Jensen.   

Abstract

Over a hundred proton-induced reactions have been studied at the University of Wisconsin Medical Physics department since the installation of the first CTI RDS 112 in 1985. The focus has been to measure thick target yields at 11 MeV, in an effort to concentrate on the practical production of positron emitting radionuclides that have favorable decay characteristics, high yields and the potential for labeling pivotal biological tracers. This review covers our recent advances to scale-up the production of the heavy halogens and transition metals as feed-stock for non-conventional PET tracers that are currently attracting increased attention in oncology.

Mesh:

Substances:

Year:  2007        PMID: 18043541      PMCID: PMC6497055     

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  3 in total

1.  Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models.

Authors:  Lei Kang; Dawei Jiang; Emily B Ehlerding; Todd E Barnhart; Dalong Ni; Jonathan W Engle; Rongfu Wang; Peng Huang; Xiaojie Xu; Weibo Cai
Journal:  Mol Pharm       Date:  2018-03-20       Impact factor: 4.939

2.  ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.

Authors:  Emily B Ehlerding; Christopher G England; Rebecca L Majewski; Hector F Valdovinos; Dawei Jiang; Glenn Liu; Douglas G McNeel; Robert J Nickles; Weibo Cai
Journal:  Mol Pharm       Date:  2017-04-12       Impact factor: 4.939

3.  CD38 as a PET Imaging Target in Lung Cancer.

Authors:  Emily B Ehlerding; Christopher G England; Dawei Jiang; Stephen A Graves; Lei Kang; Saige Lacognata; Todd E Barnhart; Weibo Cai
Journal:  Mol Pharm       Date:  2017-06-08       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.